{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:51:28Z","timestamp":1792799488768,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["MR\/R005982\/1"],"award-info":[{"award-number":["MR\/R005982\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.127013","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T19:50:23Z","timestamp":1741895423000},"page":"127013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Acceptability of the gonorrhoea human challenge model to accelerate vaccine development in UK men"],"prefix":"10.1016","volume":"54","author":[{"given":"C.","family":"Firth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Emary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vanderslott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.H.","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127013_bb0005","series-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030","author":"WHO","year":"2022"},{"issue":"40","key":"10.1016\/j.vaccine.2025.127013_bb0010","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.40.2200057","article-title":"Antimicrobial-resistant gonorrhoea: the national public health response, England, 2013 to 2020","volume":"27","author":"Merrick","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2025.127013_bb0015","series-title":"Sexually transmitted infections and screening for chlamydia in England: 2023 report","author":"UKHSA","year":"2023"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127013_bb0020","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","article-title":"Sexually transmitted infections: challenges ahead","volume":"17","author":"Unemo","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"12 Suppl 2","key":"10.1016\/j.vaccine.2025.127013_bb0025","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/infdis\/jiab227","article-title":"Gonococcal pelvic inflammatory disease: placing mechanistic insights into the context of clinical and epidemiological observations","volume":"224","author":"Xu","year":"2021","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127013_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00134-4","article-title":"WHO global research priorities for antimicrobial resistance in human health","volume":"5","author":"Bertagnolio","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2025.127013_bb0035","series-title":"Tackling drug-resistant infections globally: Final report and recommendations","author":"J ON","year":"2016"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127013_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12247767","article-title":"Neisseria gonorrhoeae antimicrobial resistance: the future of antibiotic therapy","volume":"12","author":"Raccagni","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.vaccine.2025.127013_bb0045","series-title":"WHO preferred product characteristics for gonococcal vaccines","year":"2021"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127013_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00094-23","article-title":"Neisseria gonorrhoeae vaccines: a contemporary overview","volume":"37","author":"Williams","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2025.127013_bb0055","series-title":"Microbial challenge studies of human volunteers","author":"Sciences","year":"2005"},{"key":"10.1016\/j.vaccine.2025.127013_bb0060","series-title":"Controlled human infection model studies","author":"Sciences","year":"2018"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127013_bb0065","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1016\/S1473-3099(23)00294-3","article-title":"Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy","volume":"23","author":"Abo","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127013_bb0070","series-title":"Bad blood: The Tuskegee syphilis experiment","author":"Jones","year":"1993"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127013_bb0075","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/sextrans-2012-050741","article-title":"Ethics gone awry: the US public health service studies in Guatemala; 1946-1948","volume":"89","author":"Zenilman","year":"2013","journal-title":"Sex Transm Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127013_bb0080","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1086\/598966","article-title":"Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience","volume":"199","author":"Janowicz","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127013_bb0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/978-1-4939-9496-0_25","article-title":"Experimental human infection with Neisseria gonorrhoeae","volume":"1997","author":"Hobbs","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2025.127013_bb0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmicb.2011.00123","article-title":"Experimental gonococcal infection in male volunteers: cumulative experience with Neisseria gonorrhoeae strains FA1090 and MS11mkC","volume":"2","author":"Hobbs","year":"2011","journal-title":"Front Microbiol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2025.127013_bb0095","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1086\/513847","article-title":"Human experimentation with Neisseria gonorrhoeae: progress and goals","volume":"179","author":"Cohen","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127013_bb0100","article-title":"The role of sexually transmitted infections (STI) prevention and control programs in reducing gender, sexual and STI-related stigma","volume":"33","author":"Garcia","year":"2021","journal-title":"EClinical Med."},{"issue":"4","key":"10.1016\/j.vaccine.2025.127013_bb0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1363\/4122509","article-title":"Relationships between perceived STD-related stigma, STD-related shame and STD screening among a household sample of adolescents","volume":"41","author":"Cunningham","year":"2009","journal-title":"Perspect Sex Reprod Health"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127013_bb0110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2105\/AJPH.92.3.378","article-title":"Relationships of stigma and shame to gonorrhea and HIV screening","volume":"92","author":"Fortenberry","year":"2002","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127013_bb0115","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1186\/s12889-020-09285-1","article-title":"Understanding the acceptability, barriers and facilitators for chlamydia and gonorrhoea screening in technical colleges: qualitative process evaluation of the \u201ctest n treat\u201d trial","volume":"20","author":"Fleming","year":"2020","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127013_bb0120","doi-asserted-by":"crossref","first-page":"2214054","DOI":"10.1080\/21645515.2023.2214054","article-title":"Parents\u2019 stigmatizing beliefs about the HPV vaccine and their association with information seeking behavior and vaccination communication behaviors","volume":"19","author":"McKenzie","year":"2023","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127013_bb0125","doi-asserted-by":"crossref","first-page":"e1544","DOI":"10.1016\/S2214-109X(24)00266-3","article-title":"WHO global research priorities for sexually transmitted infections","volume":"12","author":"Gottlieb","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127013_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.evalprogplan.2019.101733","article-title":"Analyzing free-text survey responses: an accessible strategy for developing patient-centered programs and program evaluation","volume":"78","author":"Abraham","year":"2020","journal-title":"Eval Program Plann"},{"key":"10.1016\/j.vaccine.2025.127013_bb0135","series-title":"Sexual orientation, UK: 2021 and 2022","author":"Statistics","year":"2023"},{"issue":"13","key":"10.1016\/j.vaccine.2025.127013_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18137179","article-title":"Shame and STIs: an exploration of emerging adult Students\u2019 felt shame and stigma towards getting tested for and disclosing sexually transmitted infections","volume":"18","author":"Scheinfeld","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"19S1","key":"10.1016\/j.vaccine.2025.127013_bb0145","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.vaccine.2024.03.068","article-title":"Review of mathematical models of Neisseria gonorrhoeae vaccine impact: implications for vaccine development","volume":"42","author":"Padeniya","year":"2024","journal-title":"Vaccine"},{"issue":"3 Suppl 2","key":"10.1016\/j.vaccine.2025.127013_bb0150","doi-asserted-by":"crossref","first-page":"19159","DOI":"10.7448\/IAS.17.3.19159","article-title":"Engaging male partners in women\u2019s microbicide use: evidence from clinical trials and implications for future research and microbicide introduction","volume":"17","author":"Lanham","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127013_bb0155","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.1139","article-title":"Effectiveness of a couple-based HIV and sexually transmitted infection prevention intervention for men in community supervision programs and their female sexual partners: a randomized clinical trial","volume":"2","author":"El-Bassel","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127013_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033796","article-title":"Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials","volume":"10","author":"Hoogerwerf","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2025.127013_bb0165","series-title":"Payment guidance for researchers and professionals Version","first-page":"4","volume":"1","author":"NIHR","year":"2023"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127013_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227898","article-title":"When money talks: judging risk and coercion in high-paying clinical trials","volume":"15","author":"Leuker","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127013_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/15265161.2020.1854368","article-title":"Promoting ethical payment in human infection challenge studies","volume":"21","author":"Lynch","year":"2021","journal-title":"Am J Bioeth"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2025.127013_bb0180","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1093\/cid\/ciad350","article-title":"Volunteering for infection: participant perspectives on a hepatitis C virus controlled human infection model","volume":"77","author":"Eberts","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127013_bb0185","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/medethics-2020-106900","article-title":"Should practice and policy be revised to allow for risk-proportional payment to human challenge study participants?","volume":"46","author":"Jamrozik","year":"2020","journal-title":"J Med Ethics"},{"issue":"26","key":"10.1016\/j.vaccine.2025.127013_bb0190","doi-asserted-by":"crossref","first-page":"126391","DOI":"10.1016\/j.vaccine.2024.126391","article-title":"Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: experience from the United Kingdom\u2019s first COVID-19 vaccine trial","volume":"42","author":"Patrick-Smith","year":"2024","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500310X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500310X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T17:43:00Z","timestamp":1762278180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2500310X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":38,"alternative-id":["S0264410X2500310X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acceptability of the gonorrhoea human challenge model to accelerate vaccine development in UK men","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127013"}}